Pages that link to "Item:Q3135016"
Jump to navigation
Jump to search
The following pages link to (Q3135016):
Displayed 15 items.
- Comparison of two HIV/HCV Infection Screening Programs in relation to the Number of New Diagnostics of HIV/HCV Infection and their Cost: Education and Support for Education and Support More External Resources (Q3204598) (← links)
- Spanish Clinical Research Network (SCReN) (Q3204784) (← links)
- Spanish Multiple Sclerosis Network (Q3206649) (← links)
- CHAPERONE MEDIATED AUTOPHAGY, MACROAUTOPHAGY AND PARKIN UBIQUITINATION IN NEURODEGENERATION. NEW THERAPEUTICAL APPROACHES (Q3208337) (← links)
- Development of a computational membrane simulator for the study of trans-hierarchic dynamics in the evolution of bacterial resistance to antibiotics. (Q3208862) (← links)
- Platform National Biobank Network (Q3211149) (← links)
- PLATFORM OF CLINICAL RESEARCH UNITS AND CLINICAL TRIALS (Q3211262) (← links)
- Improvement of the adequacy of the request for imaging tests with ionising radiation (Radiography and CT) in hospital emergency services. MAPAC-Imagen Project (Q3213139) (← links)
- Potential Benefits on the Endothelial Function of Bioactive Compounds in a Purple Garlic Extract (Q4656040) (← links)
- TIC4HTA (Q4686268) (← links)
- FARMAICTUS: New drugs for the treatment of Ictus (Q4687271) (← links)
- NEW FORMULATION TECHNOLOGIES FOR IMPROVING ACCESS OF THERAPEUTIC OLIGONUCLEOTIDES TO THE CENTRAL NERVOUS SYSTEM (Q4687311) (← links)
- Preclinical development of VCE-003.2 for the treatment of Huntington’s Disease (CANNADERIV) (Q4687543) (← links)
- AptaLung: Diagnosis of lung cancer using aptameros technology. Applications in circulating tumor cells (CTCs) and aptahistochymic (Q4692057) (← links)
- Research of a micro-organism capable of degrading gluten as well as other immunotoxic peptides from other cereals, and its development and clinical validation as a pharmaceutical product for celiac disease (Q4692179) (← links)